Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Scientists Crack How mTORC2 Selectively Activates Akt in a Longevity PathwayLongevity & Aging

Scientists Crack How mTORC2 Selectively Activates Akt in a Longevity Pathway

Researchers used semisynthetic chemical probes and cryo-electron microscopy to trap and visualize the mTORC2–Akt complex for the first time. Unlike most kinases that recognize short amino acid sequences near the phosphorylation site, mTORC2 reads the three-dimensional shape of Akt, engaging structural elements on the mSin1 subunit roughly 75 Å from the catalytic site. This mechanism explains how mTORC2 selectively phosphorylates Akt, PKC, and SGK1 while ignoring closely related kinases, and opens a path toward designing mTORC2-specific inhibitors with potential in cancer, diabetes, and aging-related diseases.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.